Skip to content

Adaptin Bio, Inc.

APTN· OTCCore metricsCIK 1938571

Biological products, except diagnostic substances175 peers

Close
Jun 29, 2026
Market cap
$55.38M
8.9M shares
Filings
78
—
—
—
-$957.34K
Q3 2026N/M FY25 yoy
-$954.38K
Q3 2026N/M FY25 yoy
—
—
—
-$0.10
Q3 2026N/M FY25 yoy
$430.33K
Q3 2026+1,247.1% FY25 yoy
$55.38M
—
—
—
—
—

FY2025 figures · derived

Price

$6.22+11.07%+$0.62since May 14, 2026
Jun 29, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$1.77MFY 2025
$1.82M0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$1,774,166reported
FY 20242024-12-31$1,824,591reported

Biological products, except diagnostic substances

Adaptin Bio, Inc. is the 122nd largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Adaptin Bio, Inc. · CIK 1938571 · Engraved from SEC EDGAR